stella
beta
Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors — Stella
Recruiting
Back to Advanced Gastroenteropancreatic Neuroendocrine Tumor trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov